A cancer patient and her Radiation Oncologist discuss how Personalized PseudoPatient™ enhances patient safety in brain radiotherapy
RTsafe's Personalized PseudoPatient™ Wins 2019 R&D 100 Award
Watch how doctors apply personalized medicine in radiation oncology using the Personalized PseudoPatient™
RTsafe’s PseudoPatient™ technology featured in new Elekta Assurance solution
RTsafe introduces the new generation of dosimetry phantoms: the PseudoPatient™
As radiation therapy becomes even more customizable to each individual patient, the complexities of the supporting treatment planning system (TPS) and the dose delivery system increase. This in turn, requires a constant evolution of quality assurance (QA) methods used to verify the performance of the systems and to implement reliable End-to-End QA and plan/treatment verification in clinical practice.

Machine QA

  • PseudoPatient™ Prime
    PseudoPatient Prime broadens the spectrum of quality assurance through an integrated solution.
  • Reference PseudoPatient™ for SRS/SRT
    RTsafe has developed high-fidelity Reference PseudoPatient™ 3D printed head phantoms of standard dimensions which enable customers to perform quality assurance end-to-end testing of their SRS/SRT systems with a high level of precision and accuracy.
  • Reference PseudoPatient™ for SBRT
    RTsafe 3D printed Reference PseudoPatient™ phantoms for SBRT are uniquely constructed to enable high accuracy dosimetric analysis and quality assurance evaluation of challenging spine radiosurgery cases testing compliance to TG-51 guidelines.

Patient QA

  • Personalized PseudoPatient™ for SRS/SRT
    RTsafe's Personalized PseudoPatient™ provides patient-specific quality assurance in radiotherapy for brain cancer. It has 510(k) FDA Clearance.



  • RTcompare is a DICOM-RT Viewer and Dose Distribution Comparison tool for radiotherapy treatment plans evaluation.
For any additional information required, please fill out the form and an RTsafe representative will respond to your request.


RTsafe announces collaboration with Hopitaux Universitaires de Geneve
13 Nov 2019
RTsafe’s Personalized PseudoPatient™ wins 2019 R&D 100 Award
01 Nov 2019
RTsafe study: Overall Spatial Uncertainty in Single Isocenter Multi-Focal SRS for Multiple Brain Metastases: End-to-End QA Results Related to 208 Targets
10 Oct 2019